Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Reddress Ltd. currently manages 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed among 4 distinct examiners, meaning each examiner is responsible for exactly one case. The prosecution activity spans 2 distinct art units, which suggests some technical variety within the Biotechnology & Pharmaceuticals sector. This distribution across 2 distinct art units requires familiarity with the procedural nuances of both groups.
OU, JING RUI is identified as the busiest examiner, although they only handle 1 pending action. Since there are 4 pending office actions and 4 distinct examiners, the workload is perfectly spread out. Practitioners must manage 4 separate interactions with 4 different examiners, each reviewing 1 pending action. This structure means that while the volume is low at 4 pending office actions, the company must address 4 individual examiner styles across 2 distinct art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OU, JING RUI | 1 | 53.3% | +51.5% |
| PEEBLES, KATHERINE | 1 | 35.5% | +48.6% |
| MENDEZ, MANUEL A | 1 | 86.0% | +8.5% |
| ALTER MORSCHAUSER, ALYSSA MARGO | 1 | 76.5% | +15.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691637 | DEVICE FOR VAGINAL TISSUE TREATMENT | MENDEZ, MANUEL A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18277511 | KIT FOR TREATING DAMAGED NERVES | ALTER MORSCHAUSER, ALYSSA MARGO | 203d overdue |
| 19170124 | ASSEMBLY AND METHOD FOR THE PREPARATION OF A WOUND DRESSING | OU, JING RUI | — |
| 18723323 | METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE | PEEBLES, KATHERINE | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19170124 | ASSEMBLY AND METHOD FOR THE PREPARATION OF A WOUND DRESSING | OU, JING RUI | — | §112DP | Non-Final OA | — | Pending | Apr 04, 2025 |
| 18723323 | METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE | PEEBLES, KATHERINE | 1617 | §103§112DP | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18691637 | DEVICE FOR VAGINAL TISSUE TREATMENT | MENDEZ, MANUEL A | — | §103 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18277511 | KIT FOR TREATING DAMAGED NERVES | ALTER MORSCHAUSER, ALYSSA MARGO | 3796 | DP | Final Rejection | 203d overdue | Pending | Aug 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial